In an international multicenter study, early recurrence in resected intraductal papillary mucinous neoplasm (IPMN)-derived pancreatic cancer was identified at 10.5 months. Among 381 patients, 42% experienced recurrence, with 38% classified as early recurrences. Key predictors included CA19-9 levels and N2 disease staging. The study stratified patients into low, intermediate, and high-risk groups, revealing that adjuvant […]

In patients with intermediate-stage hepatocellular carcinoma (HKLC stage IIB), preoperative transarterial chemoembolization (TACE) significantly improves survival outcomes compared to upfront surgery alone. A study involving 154 matched patients found that the median overall survival for the TACE group undergoing surgical resection was 90.97 months, versus 30.68 months for the surgery-only group. Additionally, disease-free survival was […]

A study involving 208 locally advanced pancreatic cancer (LAPC) patients found that those undergoing radical resection combined with intestinal autotransplantation (RRCIA) after systemic treatment significantly improved overall survival (OS) and progression-free survival (PFS). Specifically, the RRCIA group showed a median OS of 25.8 months compared to 14.2 months for those without surgery. Additionally, successful outcomes […]

Evaluating lymph nodes during surgery for perihilar cholangiocarcinoma can significantly enhance patient outcomes. In a study of 341 patients, those undergoing lymphadenectomy of stations 12, 8, and 13 demonstrated improved overall survival compared to those receiving only station 12 (HR 0.51). The highest therapeutic index was observed in patients who had six or more lymph […]

Preoperative robotic median arcuate ligament release significantly mitigates complications in pancreatoduodenectomy, particularly for patients with celiac artery stenosis. The technique demonstrates a nearly 90% success rate in resolving ischemic complications, preventing hepatic ischemia, and ensuring normal arterial flow to the gastrointestinal tract. A case involving a 49-year-old male with pancreatic adenocarcinoma highlights the effectiveness of […]

Researchers identified a pancreatic juice-specific fluorescent probe, selectively targeting ectonucleotide pyrophosphatase/phosphodiesterase (enpp) 1, from a library of 411 enzyme-activatable fluorescent probes. The probe demonstrated high reactivity with pancreatic juice, providing the potential for visualizing pancreatic juice leakage during surgery. This advancement may assist surgeons in addressing leaking sites and evaluating the need for prophylactic abdominal […]

A cohort analysis of 1,130 patients with postoperative pancreatic fistulas (popf) found that those undergoing minimally invasive pancreatoduodenectomy (mipd) faced a significantly higher risk of additional complications compared to traditional open procedures (opd). Notably, 55% of mipd-popf patients encountered a secondary complication, including a higher occurrence of postpancreatic hemorrhage (21% vs 8%). Mipd also resulted […]

Expert consensus has identified 82 best practices for delivering neoadjuvant therapy (NT) in localized pancreatic ductal adenocarcinoma (PDAC). Key areas include pre-NT evaluations, effective initiation and management during NT, and post-NT surgical and follow-up strategies. With 47 North American specialists involved, the findings aim to standardize care delivery, reduce variation, and potentially improve patient outcomes. […]

A study analyzing 1,001 pancreas ductal adenocarcinoma patients found that those from less marginalized backgrounds, indicated by the Area Deprivation Index (ADI), were 1.57 times more likely to attend follow-up appointments post-surgery compared to marginalized individuals. The study highlights significant disparities in patient follow-up rates, suggesting social determinants of health significantly influence care outcomes. This […]